Early steps in fusion between Epstein-Barr virus and a human hepatoma cell line (Li7A).
Res Virol
; 144(4): 287-91, 1993.
Article
em En
| MEDLINE
| ID: mdl-8210710
ABSTRACT
Epstein-Barr virus, the causative agent of mononucleosis and several human cancers, infects cells via complement receptor type 2 (CR2). Expression of this receptor is restricted to B lymphocytes, some epithelial cells and immature thymocytes; expression of CR2-like proteins has been also found on T cells. In the present report, we identified the presence, on the membrane of Li7A cells, of a novel EBV receptor distinct from CR2 capable of triggering fusion with EBV virions with more rapid kinetics than that found with lymphoblastoid cells (Raji).
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Receptores Virais
/
Herpesvirus Humano 4
/
Carcinoma Hepatocelular
/
Neoplasias Hepáticas
/
Fusão de Membrana
Idioma:
En
Ano de publicação:
1993
Tipo de documento:
Article